Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Mirjam de Waal"'
Autor:
Mirjam de Waal, Hans L. Zaaijer, Michel Molier, Marijke W.A. Molenaar-de Backer, Thijs J W van de Laar, Boris M. Hogema, Margret Sjerps, Peter van Swieten
Publikováno v:
Transfusion. 56:722-728
BACKGROUND The incidence of hepatitis E virus (HEV) infection in the Netherlands is high. Blood donors are not routinely screened for HEV infection, but since January 2013, donations used for the production of solvent/detergent (S/D)-treated plasma h
Publikováno v:
Transfusion. 56:440-448
BACKGROUND To meet European guidelines for plasma for fractionation, plasma fractionators have implemented parvovirus B19 (B19V) and hepatitis A virus (HAV) nucleic acid test (NAT) screening on test pools. In this study we evaluate recently developed
Autor:
Boris M, Hogema, Michel, Molier, Margret, Sjerps, Mirjam, de Waal, Peter, van Swieten, Thijs, van de Laar, Marijke, Molenaar-de Backer, Hans L, Zaaijer
Publikováno v:
Transfusion. 56(3)
The incidence of hepatitis E virus (HEV) infection in the Netherlands is high. Blood donors are not routinely screened for HEV infection, but since January 2013, donations used for the production of solvent/detergent (S/D)-treated plasma have been sc
Publikováno v:
Transfusion. 56(2)
To meet European guidelines for plasma for fractionation, plasma fractionators have implemented parvovirus B19 (B19V) and hepatitis A virus (HAV) nucleic acid test (NAT) screening on test pools. In this study we evaluate recently developed in-house N